Drugs / MAGE-A4 TCR Gene-Modified T Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01694472 | Jul 2012 → Nov 2016 | cancer | Tianjin Medical University Cancer Institute and Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MAGE-A4 TCR Gene-Modified T Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01694472 ↗ |
| Modality | Cell therapy | “MAGE-A4 TCR Gene-Modified T Cells” NCT01694472 ↗ |